New immuno-oncology antibodies: PD-L1, ICOS, and more

New PD-L1 clones   Get the best choice for your immuno-oncology research with our wide range of PD-L1 antibodies including three clones used in diagnostic IHC assays.   Discover more       ICOS   Discover the link between ICOS and CTLA-4 as immunotherapy targets using our ICOS recombinant monoclonal antibody validated for use in flow cytometry.    Find the antibody

SLAMF6   SLAMF6 is the latest immune-modulator to be investigated as a therapeutic target. Get ahead of the game and detect this receptor in flow cytometry and ICC using our recombinant monoclonal antibody.   Find out more   CD47   Our brand new IHC validated, recombinant CD47 antibody is perfect for detecting those “don’t eat me” signals in your tumor biopsies.     Take a look